Gene: Bhlhe40
Official Full Name: basic helix-loop-helix family, member e40provided by MGI
Gene Summary: This gene encodes a basic helix-loop-helix protein expressed in various tissues. The encoded protein can interact with Arntl or compete for E-box binding sites in the promoter of Per1 and repress Clock/Arntl's transactivation of Per1. This gene is believed to be involved in the control of circadian rhythm and cell differentiation. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01079 | Bhlhe40 Knockout cell line (Panc02) | Mouse | Bhlhe40 | Negative | Online Inquiry |
Bhlhe40 Gene Knockout Cell Lines are advanced research tools designed for the targeted investigation of the Bhlhe40 gene's role in cellular processes. Bhlhe40, a member of the basic helix-loop-helix (bHLH) family of transcription factors, plays a crucial role in various biological functions, including circadian rhythm regulation and immune response modulation. The knockout of this gene allows researchers to explicitly analyze its impact on gene expression, signal transduction pathways, and cellular behaviors without the background influence of Bhlhe40 activity.
These specialized cell lines function through a CRISPR/Cas9-based approach that creates site-specific mutations in the Bhlhe40 gene, effectively obliterating its expression. This precise gene-editing technique enables researchers to elucidate the downstream effects on phenotypes, emphasizing the gene's influence on pathophysiological conditions, including cancer and metabolic disorders. By providing a stable genetic background devoid of Bhlhe40, these knockout lines serve as robust models for dissecting the complexities of cellular signaling and transcriptional regulation.
The scientific importance of Bhlhe40 Gene Knockout Cell Lines extends to diverse applications in both basic research and potential therapeutic contexts. Their utilization in research settings can significantly advance our understanding of gene function, enabling studies on genetic interactions and the development of targeted therapies that could mitigate disease progressions attributed to dysregulation in transcription factors.
Unlike alternative models that may show residual expression or off-target effects, these knockout lines guarantee a complete absence of Bhlhe40, thereby offering unparalleled clarity in experimental results. This specificity is crucial for accurate data interpretation and can streamline the drug development process by revealing therapeutic windows that might be overlooked in less refined models.
For researchers and clinicians, the availability of Bhlhe40 Gene Knockout Cell Lines provides a valuable asset for investigating the intricate roles of genetics in health and disease. They foster the generation of more reliable and reproducible data that can be translated from the lab to clinical applications, enhancing the pathway towards novel therapeutic strategies.
Manufactured by a team of experts in genetic engineering and cellular biology, our company is committed to delivering high-quality biological products that empower scientific discovery. With a focus on innovation and reliability, we continuously support the research community with cutting-edge tools that advance the frontiers of biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.